Dashboard
Manage Tickers

ICCCIMMUCELL CORP /DE/

Nasdaq immucell.com


$ 4.35 $ -0.11 (-2.52 %)    

Friday, 31-May-2024 15:48:42 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ -0.84 (-0.19 %)
DIA $ 398.57 $ 6.05 (1.59 %)
SPY $ 530.36 $ 4.76 (0.91 %)
TLT $ 91.26 $ 0.61 (0.68 %)
GLD $ 225.37 $ -1.27 (-0.59 %)
$ 4.25
$ 4.28
$ 0.00 x 0
$ 0.00 x 0
$ 4.27 - $ 4.38
$ 4.25 - $ 6.05
21,026
na
32.94M
$ -0.04
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 04-01-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-29-2023 12-31-2022 10-K
7 11-21-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-30-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 03-30-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-12-2020 06-30-2020 10-Q
17 05-13-2020 03-31-2020 10-Q
18 03-27-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-12-2019 06-30-2019 10-Q
21 05-13-2019 03-31-2019 10-Q
22 03-22-2019 12-31-2018 10-K
23 11-13-2018 09-30-2018 10-Q
24 08-13-2018 06-30-2018 10-Q
25 05-14-2018 03-31-2018 10-Q
26 03-29-2018 12-31-2017 10-K
27 11-13-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
29 05-11-2017 03-31-2017 10-Q
30 03-30-2017 12-31-2016 10-K
31 11-10-2016 09-30-2016 10-Q
32 08-11-2016 06-30-2016 10-Q
33 05-11-2016 03-31-2016 10-Q
34 03-25-2016 12-31-2015 10-K
35 11-12-2015 09-30-2015 10-Q
36 08-13-2015 06-30-2015 10-Q
37 05-12-2015 03-31-2015 10-Q
38 03-26-2015 12-31-2014 10-K
39 11-12-2014 09-30-2014 10-Q
40 08-13-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

immucell-reports-73m-in-product-sales-for-quarter-ended-march-31-2024
ImmuCell Reports $7.3M In Product Sales Fo...
05/14/2024 20:28:38

immucell-anticipates-no-change-to-preliminary-sales-results-for-q1-ended-march-31-2024-that-were-disclosed-on-april-9
ImmuCell Anticipates No Change To Prelimin...
05/08/2024 17:02:12

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/09/2024 20:31:18

immucell-reports-preliminary-unaudited-sales-results-for-q1-2024-of-73m-up-111-yy
ImmuCell Reports Preliminary, Unaudited Sa...
04/09/2024 20:09:05

Total sales during the twelve-month period ended March 31, 2024 were 33% more than the twelve-month period ended March 31, 2023.

immucell-q4-2023-eps-015-up-from-022-yoy-product-sales-51m-up-from-39m-yoy
ImmuCell Q4 2023 EPS $(0.15) Up From $(0.2...
02/27/2024 22:24:03

earnings-scheduled-for-february-27-2024
Earnings Scheduled For February 27, 2024
02/27/2024 10:01:31

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

immucell-sees-prelim-q4-sales-51m-2023-sales-175m
ImmuCell Sees Prelim. Q4 Sales $5.1M, 2023...
01/08/2024 21:08:58

immucell-q3-2023-gaap-eps-012-down-from-008-yoy-sales-540m-up-from-480m-yoy
ImmuCell Q3 2023 Gaap EPS $(0.12) Down Fro...
11/13/2023 21:45:14

ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.12) per share. This is a 50 percent decrease over losses of $(0.08) per...

earnings-scheduled-for-november-13-2023
Earnings Scheduled For November 13, 2023
11/13/2023 11:40:53

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr...

immucell-announces-preliminary-unaudited-sales-results-for-q3-2023-sees-q3-revenue-54m-vs-48m-yoy
ImmuCell Announces Preliminary, Unaudited ...
10/05/2023 20:11:17

 ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures...

immucell-announced-that-it-recently-submitted-the-chemistry-manufacturing-and-controls-technical-section-for-re-tain-to-the-fda
ImmuCell Announced That It Recently Submit...
08/29/2023 12:10:46

immucell-q2-eps-018-down-from-009-yoy-sales-353m-down-from-386m-yoy
ImmuCell Q2 EPS $(0.18) Down From $(0.09) ...
08/10/2023 20:30:13

ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.18) per share. This is a 100 percent decrease over losses of $(0.09) pe...

earnings-scheduled-for-august-10-2023
Earnings Scheduled For August 10, 2023
08/10/2023 10:59:02

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share o...

why-immucell-are-trading-higher-here-are-20-stocks-moving-premarket
Why ImmuCell Are Trading Higher; Here Are ...
07/12/2023 12:19:51

Gainers Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) shares surged 131.6% to $4.03 in pre-market trading after gaining 15% on ...

angiodynamics-disney-and-3-stocks-to-watch-heading-into-wednesday
AngioDynamics, Disney And 3 Stocks To Watc...
07/12/2023 08:06:18

With U.S. stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus toda...

immucell-preliminary-q2-sales-353m-down-from-386m-yoy
ImmuCell Preliminary Q2 Sales $3.53M Down ...
07/11/2023 20:10:36

immucell-announces-change-in-timing-of-anticipated-fda-submission-says-planned-to-make-our-next-fda-submission-during-q2-of-this-year-we-have-decided-to-add-one-additional-month-to-the-projected-regulatory-development-process-for-re-tain
ImmuCell Announces Change In Timing Of Ant...
06/28/2023 20:09:06

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develop...

stocks-that-hit-52-week-lows-on-friday
Stocks That Hit 52-Week Lows On Friday
05/12/2023 17:08:19

  On Friday, 199 companies reached new 52-week lows.

immucell-q1-eps-030-down-from-007-yoy-sales-345m-down-from-600m-yoy
ImmuCell Q1 EPS $(0.30) Down From $0.07 Yo...
05/11/2023 20:37:39

ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.30) per share. This is a 528.57 percent decrease over earnings of $0.07...

earnings-scheduled-for-may-11-2023
Earnings Scheduled For May 11, 2023
05/11/2023 13:58:54

Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. •...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION